Northern Trust’s Oric Pharmaceuticals ORIC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $4.07M | Sell |
400,954
-145,792
| -27% | -$1.48M | ﹤0.01% | 2576 |
|
|
2025
Q1 | $3.05M | Sell |
546,746
-7,247
| -1% | -$40.4K | ﹤0.01% | 2688 |
|
|
2024
Q4 | $4.47M | Buy |
553,993
+28,079
| +5% | +$227K | ﹤0.01% | 2572 |
|
|
2024
Q3 | $5.39M | Buy |
525,914
+166,888
| +46% | +$1.71M | ﹤0.01% | 2430 |
|
|
2024
Q2 | $2.54M | Buy |
359,026
+5,685
| +2% | +$40.2K | ﹤0.01% | 2771 |
|
|
2024
Q1 | $4.86M | Buy |
353,341
+144
| +0% | +$1.98K | ﹤0.01% | 2472 |
|
|
2023
Q4 | $3.25M | Buy |
353,197
+10,297
| +3% | +$94.7K | ﹤0.01% | 2722 |
|
|
2023
Q3 | $2.07M | Buy |
342,900
+4,969
| +1% | +$30.1K | ﹤0.01% | 2918 |
|
|
2023
Q2 | $2.62M | Buy |
337,931
+264,208
| +358% | +$2.05M | ﹤0.01% | 2854 |
|
|
2023
Q1 | $420K | Buy |
73,723
+791
| +1% | +$4.51K | ﹤0.01% | 3537 |
|
|
2022
Q4 | $430K | Sell |
72,932
-307
| -0.4% | -$1.81K | ﹤0.01% | 3557 |
|
|
2022
Q3 | $234K | Buy |
73,239
+714
| +1% | +$2.28K | ﹤0.01% | 3811 |
|
|
2022
Q2 | $325K | Sell |
72,525
-226,333
| -76% | -$1.01M | ﹤0.01% | 3692 |
|
|
2022
Q1 | $1.6M | Sell |
298,858
-14,925
| -5% | -$79.7K | ﹤0.01% | 3204 |
|
|
2021
Q4 | $4.61M | Sell |
313,783
-3,025
| -1% | -$44.5K | ﹤0.01% | 2731 |
|
|
2021
Q3 | $6.62M | Buy |
316,808
+38,917
| +14% | +$814K | ﹤0.01% | 2559 |
|
|
2021
Q2 | $4.92M | Buy |
277,891
+47,134
| +20% | +$834K | ﹤0.01% | 2849 |
|
|
2021
Q1 | $5.65M | Sell |
230,757
-6,290
| -3% | -$154K | ﹤0.01% | 2674 |
|
|
2020
Q4 | $8.02M | Buy |
237,047
+131,125
| +124% | +$4.44M | ﹤0.01% | 2395 |
|
|
2020
Q3 | $2.65M | Sell |
105,922
-4,930
| -4% | -$123K | ﹤0.01% | 2916 |
|
|
2020
Q2 | $3.74M | Buy |
+110,852
| New | +$3.74M | ﹤0.01% | 2691 |
|